Table 1 Baseline demographic and clinical characteristics of participants who completed the study
Variables | Polygenic hypercholesterolemic patients (n = 91) | |
|---|---|---|
Age (years) | 54 ± 11 | |
Weight (kg) | 68 ± 11 | |
BMI (kg/m2) | 2 ± 3 | |
WC (cm) | 93 ± 9 | |
HC (cm) | 102 ± 6 | |
SBP (mmHg) | 120 ± 13 | |
DBP (mmHg) | 75 ± 8 | |
Glucose (mg/dL) | 91 ± 11 | |
Creatinine (mg/dL) | 0.8 ± 0.2 | |
TC (mg/dL) | 236 ± 20 | |
HDL-C (mg/dL) | 62 ± 13 | |
LDL-C (mg/dL) | 154 ± 18 | |
TG (mg/dL) | 102 ± 29 | |
Non HDL-C (mg/dL) | 174 ± 20 | |
AST (IU/L) | 20 ± 6 | |
ALT (IU/L) | 20 ± 10 | |
Prevalence | ||
Male % (n) | 37 (34) | |
Menopause status % (n) | 79 (45) | |
Smokers % (n) | 34 (31) | |
Hypertension % (n) | 26 (24) | |
Antihypertensive agents % (n) | 26 (24) | |
Antiplatelet drug % (n) | 7 (6) | |